Transfusion - Pre-compatibility Testing —
Training activity: 6

Details

Perform and interpret autoantibody investigations

Type

Developmental training activity (DTA)

Evidence requirements

Evidence the activity has been undertaken by the trainee​.

Reflection on the activity at one or more time points after the event including learning from the activity and/or areas of the trainees practice for development.

An action plan to implement learning and/or to address skills or knowledge gaps identified.

Considerations

• Haemolytic anaemia categories
• Application of testing algorithms dependent of categories
• Adsorptions
• Direct antiglobulin test (DAT)

Reflective practice guidance

The guidance below is provided to support reflection at different time points, providing you with questions to aid you to reflect for this training activity. They are provided for guidance and should not be considered as a mandatory checklist. Trainees should not be expected to provide answers to each of the guidance questions listed.

Before action

• What are the current guidelines and laboratory policies for performing and interpreting autoantibody investigations (e.g., Direct Antiglobulin Test (DAT), autocontrol)?
• What techniques are used for autoantibody investigations in your laboratory? What are the principles of these tests?
• What are the typical patterns of reactivity observed in autoantibody investigations?
• How are autoantibody investigation results interpreted in the context of pre-transfusion testing? What are the implications for compatibility testing?
• Consider the specific insights you hope to gain into the practical aspects of performing DATs and other autoantibody investigations.
• Think about your current understanding of the clinical significance of autoantibodies in transfusion practice and where you would like to expand your knowledge.
• Discuss this training activity with your training officer to understand the expected procedures and any specific scenarios you might encounter.
• Review relevant SOPs and any educational materials on autoantibody investigations.
• Consider potential challenges such as weak reactions or difficulty in differentiating auto- from alloantibodies, and think about how you might approach these.
• Reflect on your current level of understanding and confidence regarding autoantibody investigations.

In action

• How are you performing the autoantibody investigations (e.g., DAT, autocontrol)? What steps are you taking, and why are you performing them in this order?
• What decisions are you making as you perform and interpret the tests? For instance, how are you deciding which further investigations might be necessary based on the initial results?
• How effective are your actions in determining the presence and significance of autoantibodies?
• What challenges are you facing during the investigation (e.g., weak positive reactions, differentiating between auto- and alloantibodies)?
• What can you learn from the patterns of reactivity you are observing? How are these results influencing your understanding of the case?
• How does this autoantibody investigation relate to your understanding of pre-transfusion testing and potential implications for blood compatibility?
• Are there alternative investigative strategies you might consider if the initial results are inconclusive or complex (e.g., elution studies)?
• What support or guidance might you need if you encounter unexpected or difficult-to-interpret results?
• Are you ensuring that your interpretation and any subsequent actions are within established guidelines and your level of competence?

On action

• Begin by summarising the key points of the experience.
  • What autoantibody investigations did you perform (e.g., DAT, autocontrol, elution)?
  • What were the key results and your interpretation?
  • What were the key observations during the testing process?
  • Were there any difficulties in performing or interpreting the tests?
  • How did your reflect-in-action during the investigations (e.g., adjusting techniques, considering controls) impact the outcomes?
• What skills or knowledge did you develop or improve in performing and interpreting autoantibody investigations, including understanding the significance of positive results and potential implications?
  • Were there any surprises or unexpected findings during the autoantibody investigations?
  • What did you learn from these in terms of the complexity of immune reactions?
  • How does this experience relate to the broader context of pre-transfusion testing and ensuring blood safety for patients with autoantibodies?
• What areas for continued development have you identified in your understanding or practical skills related to autoantibody investigations?
  • How will you apply the knowledge gained from this activity to future cases involving potential autoantibodies?
  • What next steps will you take to reinforce your learning, such as reviewing the principles of autoantibody production or discussing challenging cases?
  • What resources or support would be beneficial for your ongoing development in this area?

Beyond action

• Have you performed other autoantibody investigations (e.g., Direct Antiglobulin Tests (DAT), elutions) since this training activity? Were the findings consistent with your understanding developed during this activity?
• How has your interpretation of positive autoantibody results evolved since then?
• Consider if you have encountered cases where autoantibodies complicated routine pre-transfusion testing. How did your learning from this training activity inform your practice in those situations? Have you discussed these cases with others to gain different perspectives?
• Has this training activity enhanced your understanding of the clinical significance of autoantibodies in the context of transfusion?
• Do you now feel more confident in interpreting different patterns of reactivity in autoantibody investigations?
• Has this experience influenced how you prioritise testing and reporting when autoantibodies are detected?
• How will your experience with autoantibody investigations prepare you for managing complex transfusion requests in patients with autoimmune conditions or haemolytic anaemia?
• Will your deeper understanding of these investigations be beneficial in understanding and contributing to discussions about transfusion strategies in patients with autoantibodies?
• How might this experience support your development in more specialised areas of transfusion science, such as haemolytic disease of the fetus and newborn (HDFN) investigations?

Relevant learning outcomes

#	Outcome
# 1	Outcome Select suitable and valid techniques for transfusion pre-compatibility testing.
# 2	Outcome Identify sequential testing algorithms appropriate to the samples under investigation for pre-compatibility testing.
# 3	Outcome Describe the limitations of methods used in pre-compatibility testing including sources of error and sample issues.
# 4	Outcome Practice in accordance with guidelines and procedures relevant to pre-transfusion testing.
# 5	Outcome Perform acceptance testing of samples requiring pre-transfusion testing and ensure samples follow appropriate testing streams relating to clinical condition.
# 6	Outcome Perform phenotyping and/or referral of genotyping to complete investigation for pre-transfusion testing.
# 8	Outcome Devise and perform investigative strategies for complex antibody identifications and transfusion reaction investigations.